Skip to main content
PMC home page
The BMJ logoLink to The BMJ
editorial
. 1991 Nov 23;303(6813):1279–1280. doi: 10.1136/bmj.303.6813.1279

Oral iron chelation is here.

G J Kontoghiorghes
PMCID: PMC1671411  PMID: 1747667

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agarwal M. B., Viswanathan C., Ramanathan J., Massil D. E., Shah S., Gupte S. S., Vasandani D., Puniyani R. R. Oral iron chelation with L1. Lancet. 1990 Mar 10;335(8689):601–601. doi: 10.1016/0140-6736(90)90380-n. [DOI] [PubMed] [Google Scholar]
  2. Bartlett A. N., Hoffbrand A. V., Kontoghiorghes G. J. Long-term trial with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1). II. Clinical observations. Br J Haematol. 1990 Oct;76(2):301–304. doi: 10.1111/j.1365-2141.1990.tb07888.x. [DOI] [PubMed] [Google Scholar]
  3. Kontoghiorghes G. J., Aldouri M. A., Hoffbrand A. V., Barr J., Wonke B., Kourouclaris T., Sheppard L. Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one. Br Med J (Clin Res Ed) 1987 Dec 12;295(6612):1509–1512. doi: 10.1136/bmj.295.6612.1509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kontoghiorghes G. J., Bartlett A. N., Hoffbrand A. V., Goddard J. G., Sheppard L., Barr J., Nortey P. Long-term trial with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1). I. Iron chelation and metabolic studies. Br J Haematol. 1990 Oct;76(2):295–300. doi: 10.1111/j.1365-2141.1990.tb07887.x. [DOI] [PubMed] [Google Scholar]
  5. Kontoghiorghes G. J. Design, properties, and effective use of the oral chelator L1 and other alpha-ketohydroxypyridines in the treatment of transfusional iron overload in thalassemia. Ann N Y Acad Sci. 1990;612:339–350. doi: 10.1111/j.1749-6632.1990.tb24321.x. [DOI] [PubMed] [Google Scholar]
  6. Kontoghiorghes G. J., Goddard J. G., Bartlett A. N., Sheppard L. Pharmacokinetic studies in humans with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one. Clin Pharmacol Ther. 1990 Sep;48(3):255–261. doi: 10.1038/clpt.1990.147. [DOI] [PubMed] [Google Scholar]
  7. Kurtzman N. A. The law and Lewis Carroll. Semin Nephrol. 1986 Mar;6(1):1–2. [PubMed] [Google Scholar]
  8. Olivieri N. F., Koren G., Hermann C., Bentur Y., Chung D., Klein J., St Louis P., Freedman M. H., McClelland R. A., Templeton D. M. Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients. Lancet. 1990 Nov 24;336(8726):1275–1279. doi: 10.1016/0140-6736(90)92962-h. [DOI] [PubMed] [Google Scholar]
  9. Töndury P., Kontoghiorghes G. J., Ridolfi-Lüthy A., Hirt A., Hoffbrand A. V., Lottenbach A. M., Sonderegger T., Wagner H. P. L1 (1,2-dimethyl-3-hydroxypyrid-4-one) for oral iron chelation in patients with beta-thalassaemia major. Br J Haematol. 1990 Dec;76(4):550–553. doi: 10.1111/j.1365-2141.1990.tb07915.x. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES